CytoDyn (CYDY) Other Non Operating Income (2014 - 2025)
CytoDyn (CYDY) posted Other Non Operating Income of -$7000.0 for Q2 2025, down 102.14% on a QoQ basis from $327000.0 in Q1 2025, and up 99.9% year-over-year from -$3501.7 in Q2 2024.
CytoDyn (CYDY) Other Non Operating Income (2014 - 2025) Analysis & Trends
CytoDyn's Other Non Operating Income history runs 12 years deep, the most recent figure standing at -$7000.0 for Q2 2025.
- Quarterly Other Non Operating Income rose 99.9% year-over-year to -$7000.0 in Q2 2025, while the trailing twelve-month figure through May 2025 was -$6.9 million (up 48.15% YoY) and the FY2025 annual result came in at $400000.0, up 102.99% from the prior year.
- Other Non Operating Income was -$7000.0 for Q2 2025 at CytoDyn, down from $327000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $327000.0 in Q1 2025 and bottomed at -$8.1 million in Q2 2021.
- A 5-year average of -$3.3 million and a median of -$2.8 million in 2022 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2021 — Other Non Operating Income tumbled 159.88% — and 2025, when it jumped 121.1%.
- CytoDyn's Other Non Operating Income stood at -$3.3 million in 2021, then grew by 6.13% to -$3.1 million in 2022, then increased by 22.61% to -$2.4 million in 2023, then surged by 103.33% to $80000.0 in 2024, then plunged by 108.75% to -$7000.0 in 2025.
- Business Quant data shows CYDY's Other Non Operating Income at -$7000.0 in Q2 2025, $327000.0 in Q1 2025, and $80000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | CytoDyn | 267.79 Mn | 267.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2025 | -7,000.00 |
| Feb 28, 2025 | 327,000.00 |
| Nov 30, 2024 | 80,000.00 |
| May 31, 2024 | -7.33 Mn |
| Feb 29, 2024 | -1.55 Mn |
| Nov 30, 2023 | -2.41 Mn |
| Aug 31, 2023 | -2.08 Mn |
| Feb 28, 2022 | -3.11 Mn |
| Nov 30, 2021 | -3.31 Mn |
| Aug 31, 2021 | -4.65 Mn |
| May 31, 2021 | -8.10 Mn |
| Feb 28, 2021 | -7.63 Mn |
| Nov 30, 2020 | -4.17 Mn |
| May 31, 2020 | -7.44 Mn |
| Feb 29, 2020 | -2.93 Mn |
| Nov 30, 2019 | 203,000.00 |
| Aug 31, 2019 | 625,000.00 |
| May 31, 2019 | 784,505.00 |
| Feb 28, 2019 | 1.35 Mn |
| Nov 30, 2018 | -1.52 Mn |